Advertisement
Snapshots from the nation’s busiest noninvasive vascular laboratory
Cleveland Clinic is home to the largest and busiest noninvasive vascular laboratory in the U.S., with more than 2,220 clinical vascular imaging studies performed monthly.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
These studies include duplex venous ultrasonography for assessing lower extremity venous obstruction, venous insufficiency, varicose veins or venous valvular reflux disease, all of which can lead to delayed venous wound healing (Figure 1).
Figure 1. (Top) A representative short-axis grayscale ultrasound image showing venous insufficiency of the great saphenous vein (white arrow). Note the dilated vein, which is considered a varicose vein. (Bottom) Example of a longitudinal grayscale image (orange arrow) of the same varicose vein showing valvular incompetency as a function of reversal of venous flow (blue star). This phenomenon often leads to nonhealing leg venous ulcers.
Besides serial debridement and wound bed preparation, our vascular medicine physicians use various wound dressing materials to absorb wound drainage and mobilize cellular matrix to promote wound healing (Figure 2). Additionally, multilayer compression garments are commonly used for patients with venous wounds to reduce leg swelling and venous hypertension.
Figure 2. Section of Vascular Medicine staff physician Geoffrey Ouma, DO, tends to a patient’s lower extremity venous wound.
Cleveland Clinic’s vascular medicine specialists also collaborate with their vascular interventionalist colleagues to help restore arterial flow to the leg in cases of arterial obstruction and to employ endovenous laser ablation to treat varicose veins associated with venous leg wounds.
Advertisement
Advertisement
Large cohort study finds significant effect in men and nonsmokers
Cleveland Clinic series supports its feasibility, especially with HeartMate 3
Questions remain following late mortality signal from a retrospective cohort study
TAVR explant demands multidisciplinary expertise
How two of our surgeons are working for care equity, greater representation in research and practice
Judicious application yields a 99.7% repair rate and 0.04% mortality
Studies reveal increased cardiac events, enhanced platelet reactivity and thrombotic potential
Large single-center series demonstrates safety and efficacy for extending procedure